Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v2.4.0.6
Condensed Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Revenues $ 233,832   $ 554,180  
Operating expenses:        
Research and development 1,162,320 619,536 2,618,960 777,079
General and administrative 1,745,156 1,245,780 2,933,890 2,459,044
2,907,476 1,865,316 5,552,850 3,236,123
Operating loss (2,673,644) (1,865,316) (4,998,670) (3,236,123)
Other income (expense):        
Interest income 608 3,502 2,206 4,197
Interest expense (16,800) (12,926) (26,376) (26,051)
Royalty income 5,408 3,506 17,063 10,204
Change in the fair value of derivative instrument 1,086,768 (2,839,227) 3,791,260 (4,280,619)
1,075,984 (2,845,145) 3,784,153 (4,292,269)
Net Loss $ (1,597,660) $ (4,710,461) $ (1,214,517) $ (7,528,392)
Net loss per common share - basic and diluted (in Dollars per share) $ (0.05) $ (0.15) $ (0.04) $ (0.25)
Weighted average common shares outstanding - basic and diluted (in Shares) 32,382,095 30,926,018 32,382,095 29,599,336